Improving Management of Sickle Cell Disease (SCD) with Ease

New Orleans, LA US
January 20, 2022

This activity will provide pharmacists, residents, and pharmacy technicians with information on background, barriers of care, and therapy options for sickle cell disease and its complications. The information provided will aid in determining how to provide safe and efficacious therapy options for patients with sickle cell disease. Problems related to SCD are controlled with hydroxyurea, blood transfusions, and opioids. Even with the mainstays of therapy, patients may experience multiple vaso-occlusive crisis (VOC) episodes leading to hospitalizations. Recent therapeutic developments have allowed patients who are unable to tolerate hydroxyurea to have different therapeutic options. These specialty medications include l-glutamine, voxelotor, crizanlizumab, and rivipansel. This CE will examine peer reviewed literature to determine their place in therapy in managing various complications of SCD.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe SCD’s different phenotypes and implications for therapy
  2. Review established treatment regimens for SCD
  3. Evaluate the literature on recently approved therapies for the treatment of SCD

Pharmacy technician learning objectives

  1. Discuss barriers of care for patients with SCD
  2. Identify acute and chronic complications of SCD
  3. Recognize brand and generic names of new therapies used in treatment of SCD
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
Course expires: 
Event starts: 
01/20/2022 - 12:00pm CST
Event ends: 
01/20/2022 - 1:00pm CST
Ochsner Medical Center
1415 Jefferson Hwy.
New Orleans, LA 70121
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose.
Planning committee
Miranda Dermady, PharmD, BCPS
Internal Medicine Clinical Pharmacist
Ochsner Health
Victoria Sawyer, PharmD
PGY1 Pharmacy Resident
Ochsner Health
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-22-096-L01-P
Universal Activity Number: JA0006103-9999-22-096-L01-T

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Please login or register to take this course.